注册 | 登录 | FAQ      [?] 

Cancer Gene Therapy

最近几期的文章@ Cancer Gene Therapy © Nature Publishing Group
  • E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer
    Cancer Gene Therapy, Vol. aop, No. current.
    by K Fukuda, M Abei, H Ugai, R Kawashima, E Seo, M Wakayama, T Murata, S Endo, H Hamada, I Hyodo, KK Yokoyama
  • Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model
    Cancer Gene Therapy, Vol. aop, No. current.
    by F Kamlah, BG Eul, S Li, N Lang, LM Marsh, W Seeger, F Grimminger, F Rose, J Hänze
  • Exploiting the tumor microenvironment in the development of targeted cancer gene therapy
    Cancer Gene Therapy, Vol. aop, No. current.
    by GJ Dougherty, ST Dougherty
  • Hapten-derivatized nanoparticle targeting and imaging of gene expression by multimodality imaging systems
    Cancer Gene Therapy, Vol. aop, No. current.
    by CM Cheng, PY Chu, KH Chuang, SR Roffler, CH Kao, WL Tseng, J Shiea, WD Chang, YC Su, BM Chen, YM Wang, TL Cheng
  • Recent advances in p53 research: an interdisciplinary perspective
    Cancer Gene Therapy, Vol. aop, No. current.
    by M Olivier, A Petitjean, V Marcel, A Pétré, M Mounawar, A Plymoth, CC de Fromentel, P Hainaut
  • Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter
    Cancer Gene Therapy, Vol. aop, No. current.
    by M Ahn, SJ Lee, X Li, JA Jiménez, YP Zhang, KH Bae, Y Mohammadi, C Kao, TA Gardner
  • Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer
    Cancer Gene Therapy, Vol. aop, No. current.
    by LP Lefter, S Dima, M Sunamura, T Furukawa, Y Sato, M Abe, M Chivu, I Popescu, A Horii
  • Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo
    Cancer Gene Therapy, Vol. aop, No. current.
    by MS Song, JS Jeong, G Ban, JH Lee, YS Won, KS Cho, IH Kim, SW Lee
  • Growth inhibition of an established A431 xenograft tumor by a full-length anti-EGFR antibody following gene delivery by AAV
    Cancer Gene Therapy, Vol. aop, No. current.
    by DT Ho, S Wykoff-Clary, CS Gross, D Schneider, F Jin, PJ Kretschmer, TW Hermiston
  • PET imaging of heat-inducible suicide gene expression in mice bearing head and neck squamous cell carcinoma xenografts
    Cancer Gene Therapy, Vol. aop, No. current.
    by JJ Parry, V Sharma, R Andrews, EG Moros, D Piwnica-Worms, BE Rogers
  • Transferrin lipoplex-mediated suicide gene therapy of oral squamous cell carcinoma in an immunocompetent murine model and mechanisms involved in the antitumoral response
    Cancer Gene Therapy, Vol. aop, No. current.
    by S Neves, H Faneca, S Bertin, K Konopka, N Düzgüneş, V Pierrefite-Carle, S Simões, Pedroso MC de Lima
  • Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo
    Cancer Gene Therapy, Vol. aop, No. current.
    by MP Rubinstein, ML Salem, AN Kadima, CL Nguyen, WE Gillanders, MI Nishimura, DJ Cole
  • Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA
    Cancer Gene Therapy, Vol. aop, No. current.
    by JN Zheng, DS Pei, LJ Mao, XY Liu, DD Mei, BF Zhang, Z Shi, RM Wen, XQ Sun
  • An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors
    Cancer Gene Therapy, Vol. aop, No. current.
    by N Lei, FB Shen, JH Chang, L Wang, H Li, C Yang, J Li, DC Yu
  • TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma
    Cancer Gene Therapy, Vol. aop, No. current.
    by M Enderlin, EV Kleinmann, S Struyf, C Buracchi, A Vecchi, R Kinscherf, F Kiessling, S Paschek, S Sozzani, J Rommelaere, JJ Cornelis, J Van Damme, C Dinsart
  • Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model
    Cancer Gene Therapy, Vol. aop, No. current.
    by MA Shibata, J Morimoto, E Shibata, Y Otsuki
  • IL-18-producing Salmonella inhibit tumor growth
    Cancer Gene Therapy, Vol. aop, No. current.
    by M Loeffler, G Le'negrate, M Krajewska, JC Reed
  • Early RB94-produced cytotoxicity in cancer cells is independent of caspase activation or 50 kb DNA fragmentation
    Cancer Gene Therapy, Vol. aop, No. current.
    by J Zhou, XQ Zhang, F Ashoori, DJ Mcconkey, MA Knowles, L Dong, WF Benedict
  • Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors
    Cancer Gene Therapy, Vol. aop, No. current.
    by Y Gao, P Whitaker-Dowling, JA Griffin, MA Barmada, I Bergman
  • Chimeric form of tumor necrosis factor-α has enhanced surface expression and antitumor activity
    Cancer Gene Therapy, Vol. aop, No. current.
    by R Rieger, D Whitacre, MJ Cantwell, C Prussak, TJ Kipps
  • REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer
    Cancer Gene Therapy, Vol. aop, No. current.
    by K Kawasaki, M Watanabe, M Sakaguchi, Y Ogasawara, K Ochiai, Y Nasu, H Doihara, Y Kashiwakura, N-H Huh, H Kumon, H Date
  • Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth
    Cancer Gene Therapy, Vol. aop, No. current.
    by G Jeudy, F Salvadori, B Chauffert, E Solary, P Vabres, J Chluba
  • Intratumoral gene delivery of anti-cathepsin L single-chain variable fragment by lentiviral vector inhibits tumor progression induced by human melanoma cells
    Cancer Gene Therapy, Vol. aop, No. current.
    by R Frade, N Rousselet, D Jean
  • Adenovirus-mediated HCCS1 overexpression elicits a potent antitumor efficacy on human colorectal cancer and hepatoma cells both in vitro and in vivo
    Cancer Gene Therapy, Vol. aop, No. current.
    by Y Gan, J Gu, X Cai, J Hu, XY Liu, X Zhao
  • Conditioned medium from Ad-IFN-α-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect
    Cancer Gene Therapy, Vol. aop, No. current.
    by X Zhang, L Dong, E Chapman, WF Benedict
  • Adenovirus-mediated gene transfer of interleukin-23 shows prophylactic but not therapeutic antitumor effects
    Cancer Gene Therapy, Vol. aop, No. current.
    by HT Jin, JI Youn, SY Choi, SH Seo, SH Park, MY Song, SH Yang, YC Sung
  • Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD
    Cancer Gene Therapy, Vol. aop, No. current.
    by JI Youn, SH Park, HT Jin, CG Lee, SH Seo, MY Song, CW Lee, YC Sung
  • E. coli nitroreductase/CB1954 gene-directed enzyme prodrug therapy: role of arylamine N-acetlytransferase 2
    Cancer Gene Therapy, Vol. aop, No. current.
    by DJ Mitchell, RF Minchin
  • Bystander effect in glioblastoma cells with a predominant cytoplasmic localization of connexin43
    Cancer Gene Therapy, Vol. aop, No. current.
    by S Cottin, K Ghani, M Caruso
  • ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice
    Cancer Gene Therapy, Vol. aop, No. current.
    by HV Reddi, P Madde, AJ Reichert-Eberhardt, EC Galanis, JA Copland, B Mciver, SKG Grebe, NL Eberhardt
  • Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells
    Cancer Gene Therapy, Vol. aop, No. current.
    by W Song, Z Dong, T Jin, MG Mantellini, G Núñez, JE Nör
  • Adenoviral-mediated Rybp expression promotes tumor cell-specific apoptosis
    Cancer Gene Therapy, Vol. aop, No. current.
    by RL Novak, AC Phillips
  • Hypoxia-induced human endonuclease G expression suppresses tumor growth in a xenograft model
    Cancer Gene Therapy, Vol. aop, No. current.
    by PT Winnard, M Botlagunta, JB Kluth, S Mukadam, B Krishnamachary, F Vesuna, V Raman
  • Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication
    Cancer Gene Therapy, Vol. aop, No. current.
    by YY Mahller, B Sakthivel, WH Baird, BJ Aronow, YH Hsu, TP Cripe, R Mehrian-Shai
  • HSV-1 amplicon viral vector-mediated gene transfer to human bone marrow-derived mesenchymal stem cells
    Cancer Gene Therapy, Vol. aop, No. current.
    by IAW Ho, KYW Chan, L Miao, WSN Shim, CM Guo, P Cheang, KM Hui, PYP Lam
  • Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo
    Cancer Gene Therapy, Vol. aop, No. current.
    by DB Xiang, ZT Chen, D Wang, MX Li, JY Xie, YS Zhang, Y Qing, ZP Li, J Xie
  • Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
    Cancer Gene Therapy, Vol. aop, No. current.
    by B Yaacov, E Elihaoo, I Lazar, M Ben-Shlomo, I Greenbaum, A Panet, Z Zakay-Rones
  • JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase
    Cancer Gene Therapy, Vol. aop, No. current.
    by W Hu, W Hofstetter, W Guo, H Li, A Pataer, HH Peng, ZS Guo, DL Bartlett, A Lin, SG Swisher, B Fang
  • Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy
    Cancer Gene Therapy, Vol. aop, No. current.
    by Y Gao, SSM Ng, DHW Chau, H Yao, C Yang, K Man, PT Huang, C Huang, JJ Huang, HF Kung, MC Lin
  • Dual induction of PKR with E2F-1 and IFN-α to enhance gene therapy against hepatocellular carcinoma
    Cancer Gene Therapy, Vol. aop, No. current.
    by V Roh, A Laemmle, U Von Holzen, D Stroka, JF Dufour, KK Hunt, D Candinas, SA Vorburger
  • Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck
    Cancer Gene Therapy, Vol. aop, No. current.
    by P Michaluart, KA Abdallah, FD Lima, R Smith, RA Moysés, V Coelho, GD Victora, A Socorro-Silva, EC Volsi, CR Zárate-Bladés, AR Ferraz, AK Barreto, MC Chammas, R Gomes, E Gebrim, L Arakawa-Sugueno, KP Fernandes, PA Lotufo, MR Cardoso, J Kalil, CL Silva
  • Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model
    Cancer Gene Therapy, Vol. aop, No. current.
    by F Solly, R Fish, B Simard, N Bolle, E Kruithof, B Polack, G Pernod
  • Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy
    Cancer Gene Therapy, Vol. aop, No. current.
    by KF Hsu, CL Wu, SC Huang, JL Hsieh, YS Huang, YF Chen, MR Shen, WJ Chung, CY Chou, AL Shiau
  • Radiation improves gene delivery by a novel transferrin-lipoplex nanoparticle selectively in cancer cells
    Cancer Gene Therapy, Vol. aop, No. current.
    by RA Abela, J Qian, L Xu, TS Lawrence, M Zhang
  • A dual role of p21waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate
    Cancer Gene Therapy, Vol. aop, No. current.
    by Kraljevic S Pavelic, T Cacev, M Kralj
  • Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts
    Cancer Gene Therapy, Vol. aop, No. current.
    by Q Leng, P Scaria, P Lu, MC Woodle, AJ Mixson
  • In vivo persistence of genetically modified T cells generated ex vivo using the fibronectin CH296 stimulation method
    Cancer Gene Therapy, Vol. aop, No. current.
    by SS Yu, I Nukaya, T Enoki, E Chatani, A Kato, Y Goto, K Dan, M Sasaki, K Tomita, M Tanabe, H Chono, J Mineno, I Kato
  • Synergistic antitumor efficacy of suicide/ePNP gene and 6-methylpurine 2′-deoxyriboside via Salmonella against murine tumors
    Cancer Gene Therapy, Vol. aop, No. current.
    by W Fu, H Lan, S Li, X Han, T Gao, D Ren
  • Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice
    Cancer Gene Therapy, Vol. aop, No. current.
    by S Sas, T Chan, A Sami, A El-Gayed, J Xiang
  • Antiangiogenic systemic gene therapy combined with doxorubicin administration induced caspase 8 and 9-mediated apoptosis in endothelial cells and an anti-metastasis effect
    Cancer Gene Therapy, Vol. aop, No. current.
    by M Peled, A Shaish, S Greenberger, A Katav, I Hodish, D Ben-Shushan, I Barshack, I Mendel, L Frishman, R Tal, L Bangio, E Breitbart, D Harats
    • ◇温馨提示◇本页的引用地址为： http://www.citeulike.org/journal/cancer-gene-therapy-aop

    Result page: 1 2 3 4 5 6 7 8 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.